MedTrace Logo

Saudi Emergency Laparotomy Audit

NCT07429929 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-02-24

No results posted yet for this study

Summary

The Saudi Emergency Laparotomy Audit (SELA) is a national, multicenter observational clinical audit designed to evaluate outcomes and quality of care for patients undergoing emergency laparotomy in Saudi Arabia. The audit will collect standardized data on patient characteristics, comorbidities, perioperative processes, and postoperative outcomes through a retrospective baseline phase followed by a prospective registry phase. SELA aims to establish national benchmarks, assess applicability of international risk models, support development of a Saudi-specific risk prediction tool, and drive quality improvement through systematic feedback and benchmarking across participating hospitals.

Conditions

  • Laparotomy
  • Laparotomy Surgery
  • Emergency Treatment
  • Abdominal Diseases
  • Gastrointestinal Diseases
  • Intestinal Obstruction
  • Intestinal Obstruction and Ileus
  • Intestinal Perforation
  • Intestinal Ischemia
  • Peritonitis Infectious, Gastrointestinal Perforation, Surgical Infection, Postoperative Complications
  • Peritonitis Bacterial
  • Peritonitis Caused by Perforated Left-sided Colon Diverticulitis
  • Peritonitis Infectious
  • Sepsis
  • Postoperative Complications After Gastrointestinal Operations
  • Surgical Procedures, Operative
  • Mortality

Interventions

PROCEDURE

Emergency Laparotomy

Emergency laparotomy performed as part of routine clinical care for acute intra-abdominal surgical conditions. This audit observes outcomes following emergency laparotomy without altering standard perioperative management, with data collected retrospectively from existing clinical records.

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07429929 on ClinicalTrials.gov